Immediate Impact
1 by Nobel laureates 58 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Works of Juliane Manitz being referenced
Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival
2022
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Juliane Manitz | 144 | 144 | 51 | 68 | 26 | 391 | |
| Biwei Cao | 45 | 83 | 53 | 11 | 34 | 382 | |
| Tülay Özçelik | 47 | 121 | 22 | 37 | 31 | 407 | |
| Xiaoqing Liu | 144 | 131 | 13 | 27 | 34 | 386 | |
| Edward D. Crum | 55 | 118 | 44 | 26 | 28 | 444 | |
| Jimmy S. Patel | 17 | 45 | 104 | 29 | 40 | 407 | |
| A Kohno | 29 | 141 | 33 | 27 | 22 | 439 | |
| Ahmet Tunalı | 46 | 149 | 18 | 50 | 21 | 419 | |
| Baldeep Wirk | 20 | 103 | 31 | 23 | 32 | 337 | |
| Harumi Saeki | 43 | 163 | 49 | 5 | 35 | 353 | |
| S. Humphreys | 38 | 76 | 18 | 16 | 25 | 338 |
All Works
Login with ORCID to disown or claim papers
Loading papers...